MedTrace Logo

Modulating the GIP System in Patients With Acromegaly Due to a Pituitary Tumor

NCT03807076 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2023-11-29

No results posted yet for this study

Summary

Modulation of the GIP System in Patients With Acromegaly Due to a Pituitary adenoma

Conditions

  • Acromegaly Due to Pituitary Adenoma

Interventions

OTHER

GIP-A

GIP-A

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    collaborator OTHER

  • Aarhus University Hospital

    collaborator OTHER

  • Aalborg University Hospital

    collaborator OTHER

  • Odense University Hospital

    collaborator OTHER

  • Herlev and Gentofte Hospital

    collaborator OTHER

  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Mette H Jensen, MSc · Department of Biomedical Sciences

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-13
Primary Completion
2023-06-14
Completion
2023-11-28

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03807076 on ClinicalTrials.gov